We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01384786
Recruitment Status : Completed
First Posted : June 29, 2011
Last Update Posted : June 29, 2011
Sponsor:
Information provided by:

Study Description
Brief Summary:

Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated.

The investigators have found that thyroid cancer is not overlooked.


Condition or disease
Hyperthyreosis and Goiter Thyroid Cancer

Study Design

Study Type : Observational
Actual Enrollment : 4474 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter
Study Start Date : October 2004
Study Completion Date : July 2005

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Radioiodine treated patients
Criteria

Inclusion Criteria:

  • all patients treated with radioiodine
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01384786


Locations
Denmark
herlev Hospital
Copenhagen, Denmark
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Investigators
Study Chair: Anders Vej-Hansen Herlev Hospital, Copenhagen, Denmark
More Information

Responsible Party: Birte Nygaard md PhD, dept of endocinology O 106
ClinicalTrials.gov Identifier: NCT01384786     History of Changes
Other Study ID Numbers: JCEM070948
First Posted: June 29, 2011    Key Record Dates
Last Update Posted: June 29, 2011
Last Verified: June 2011

Additional relevant MeSH terms:
Thyroid Diseases
Thyroid Neoplasms
Goiter
Hyperthyroidism
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Head and Neck Neoplasms